Human Amyloid-β (1-42) Peptide (Trifluoroacetate Salt)

Neurotoxic peptide fragment

Human Amyloid-β (1-42) Peptide (Trifluoroacetate Salt)

Neurotoxic peptide fragment

From: 555 USD
Catalog #
100-0899_C
Neurotoxic peptide fragment

Overview

Human Amyloid-β (1-42) Peptide is a neurotoxic peptide fragment that can oligomerize to form amyloid plaques, thus contributing to the onset of Alzheimer's disease (Paradis et al.; Teplow; Wolfe). These neurotoxic peptide fragments also modulate the expression of Bcl-2 and Bax in human neurons (Paradis et al.).

NOTE: Human Amyloid-β (1-42) Peptide oligomers and fibrils are considered neurotoxic. Please contact your workplace safety committee for guidance before planning any work using Human Amyloid-β (1-42) Peptide.

DISEASE MODELING
· Induces neuronal death in human neurons in vitro and in vivo (Paradis et al.).
· Increases production of TNF-α in rat astrocytes (Hughes et al.).
Alternative Names
Aβ (1-42); Aβ42
Cell Type
Neurons
Area of Interest
Disease Modeling, Neuroscience
Purity
≥ 95 %

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
100-0899
Lot #
All
Language
English
Document Type
Safety Data Sheet
Catalog #
100-0899
Lot #
All
Language
English

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.